STOCK TITAN

iSpecimen (ISPC) Stock News, Feb-May 2022

ISPC NASDAQ

iSpecimen Inc. reports developments tied to its online marketplace for human biospecimens, which connects life science researchers with a network of healthcare specimen providers. Company updates cover biospecimen sourcing for research projects, supplier-network responsiveness, direct-to-customer shipping, and marketplace technology used to match customer requests with available inventory.

Recurring news themes include AI-assisted inventory matching, SalesStack marketplace integration, respiratory and other specimen procurement, international sourcing relationships, and capital-structure actions such as the completed reverse stock split of ISPC common stock.

Rhea-AI Summary

iSpecimen (Nasdaq: ISPC), a leading online marketplace for biospecimens, announced that CEO Christopher Ianelli will participate virtually in the H.C. Wainwright Global Investment Conference from May 23-26, 2022. His presentation will be accessible on-demand starting May 24, 2022, at 7:00 a.m. ET. The conference aims to connect scientists with healthcare providers for medical research. iSpecimen’s platform facilitates searching for human biospecimens through a cloud-based network, enhancing medical discoveries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.82%
Tags
conferences
-
Rhea-AI Summary

iSpecimen Inc. (Nasdaq: ISPC) reported Q1 2022 revenue of approximately $2.5 million, down from $3.0 million year-over-year, impacted by the Ukraine-Russia conflict affecting supply chains. The company managed to transition $1.0 million in open purchase orders to other suppliers, demonstrating marketplace adaptability. Unique customers rose by 25% to 437, and supplier organizations increased to 205. General and administrative expenses rose to $1.8 million due to increased costs. Net loss for the quarter was about $2.4 million, with cash reserves at approximately $26.1 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.99%
Tags
-
Rhea-AI Summary

iSpecimen Inc. (Nasdaq: ISPC) announced plans to report its financial results for Q1 2022 on May 10, 2022, before market opening. The company connects researchers with biospecimens through an online marketplace. A conference call will be held at 8:30 a.m. ET that same day, featuring CEO Christopher Ianelli and other executives. Interested participants can join via phone or webcast, with a replay available until May 24, 2022. iSpecimen specializes in facilitating medical research by linking scientists with healthcare providers for essential specimens.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.25%
Tags
conferences earnings
Rhea-AI Summary

iSpecimen (Nasdaq: ISPC) has launched an enhanced iSpecimen Marketplace® platform that improves search capabilities and data integration for biospecimen procurement. The updated interface features a Google-like search bar and advanced matching algorithms, allowing researchers to find the specific human biospecimens they need. Suppliers can access their inventories more easily, while new data fields enhance the search process. The marketplace remains free for both suppliers and researchers, aiming to streamline the connection between scientists and medical samples critical for research.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.54%
Tags
none
-
Rhea-AI Summary

iSpecimen Inc. (Nasdaq: ISPC) has partnered with Acutis Diagnostics to enhance its biospecimen marketplace platform, introducing custom sequencing services for cancer and COVID-19 samples. This collaboration aims to streamline the research process by providing a single source for samples and corresponding sequencing data, improving researchers' ability to study genetic mutations linked to these diseases. Given the high demand for biospecimens related to cancer and COVID-19, this initiative is set to foster advancements in medical diagnostics and therapeutics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.71%
Tags
none
-
Rhea-AI Summary

iSpecimen (Nasdaq: ISPC) has announced that CEO Christopher Ianelli will participate in the Maxim Group’s 2022 Virtual Growth Conference from March 28-30, 2022. The corporate presentation will be available on-demand starting March 28, 2022, at 9:00 a.m. ET for all registrants. iSpecimen connects scientists with healthcare providers through its online marketplace for biospecimens essential for medical research. For more details about the conference or one-on-one meetings, attendees can reach out to Maxim representatives or KCSA Strategic Communications.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.22%
Tags
conferences
Rhea-AI Summary

iSpecimen Inc. (Nasdaq: ISPC) announced its marketplace network has exceeded 200 healthcare providers, significantly enhancing access to biospecimens for medical research. This platform connects researchers with healthcare organizations, improving procurement efficiency for crucial samples such as tissues and biofluids. The diverse supplier network ensures a reliable flow of specimens, addressing potential shortages from global disruptions. The company emphasizes compliance and rigorous vetting for its suppliers to maintain high ethical and operational standards.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
none
-
Rhea-AI Summary

iSpecimen Inc. (Nasdaq: ISPC) reported a record FY 2021 revenue of $11.1 million, a 36% increase from FY 2020's $8.2 million. The revenue consisted of $8.0 million (72%) from non-COVID-19 related sources and $3.1 million (28%) from COVID-19. The company expanded its supplier network to 200 organizations and customer purchases grew to 415. iSpecimen raised $21 million in a private placement, enhancing its capabilities for biospecimen research. However, net loss increased to $9.0 million from $4.7 million in 2020.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.93%
Tags
-
Rhea-AI Summary

iSpecimen (NASDAQ: ISPC) announced CEO Dr. Christopher Ianelli's participation in the Aegis Capital Corp. Virtual Conference from February 23-25, 2022. Dr. Ianelli will present on February 24 at 12:30 p.m. ET. Interested attendees can add the event to their calendars via an iCalendar link. iSpecimen operates an online marketplace for human biospecimens, enabling life scientists to connect with healthcare providers for research needs. For further inquiries or one-on-one meetings, contact KCSA Strategic Communications.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.66%
Tags
conferences
Rhea-AI Summary

iSpecimen Inc. (NASDAQ: ISPC) will release its fourth quarter and full year financial results for 2021 on February 17, 2022, before market opening. An audio webcast will follow at 8:30 a.m. ET, featuring key executives including CEO Christopher Ianelli. Investors can join the live call at +1-877-425-9470 (U.S.) or +1-201-389-0878 (International). A replay option will be available until March 3, 2022. iSpecimen offers a marketplace for human biospecimens, connecting researchers with healthcare providers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.05%
Tags
conferences earnings

FAQ

What is the current stock price of iSpecimen (ISPC)?

iSpecimen (ISPC) last closed at $0.5961.

What is the market cap of iSpecimen (ISPC)?

The market cap of iSpecimen (ISPC) is approximately $1.5M.